Rainbow at shoreline

The Massachusetts ME/CFS & FM Association, a 501(c)3 founded in 1985, exists to meet the needs of patients with ME (Myalgic Encephalomyelitis), CFS (Chronic Fatigue Syndrome) or FM (Fibromyalgia), their families and loved ones. The Massachusetts ME/CFS & FM Association works to educate health-care providers and the general public regarding these severely-disabling physical illnesses. We also support patients and their families and advocate for more effective treatment and research.

Research articles

Fibromyalgia studies 2012

This is a recap of studies and relevant articles on Fibromyalgia which were published during 2012 (formerly posted on our News around the Web page).

"Working Memory Impairment in Fibromyalgia Patients Associated with Altered Frontoparietal Memory Network" (PLoS One) A study conducted by Korean researchers using functional magnetic resonance imaging (fMRI) to demonstrate differences in working memory between FM patients and healthy subjects.

Cardiac autonomic impairment and chronotropic incompetence in fibromyalgia
(da Cunha Ribeiro et al, Arthritis Research & Therapy 2011, 13:R190 doi:10.1186/ar3519) Research by a team of rheumatologists at University of Sao Paulo School of Medicine, Brazil, that found some patients with FM experienced various cardiac irregularities in response to exercise.

Autonomic dysfunction in women with fibromyalgia — an editorial in response to the article published by Ribeiro and colleagues in Arthritis Research & Therapy, supporting the finding of autonomic dysfunction at rest in FM patients.

Research on Fibromyalgia Skin Sensitivities (Fibromyalgia Network) Researchers provide answers about what might be causing itchy or burning sensations and other skin sensitivities frequently experienced in FM.

New Device Cuts Fibromyalgia Pain in Pilot Study (Clinical Psychiatry News Digital Network) Results from a small pilot study of FM patients who were treated with an investigational transcranial stimulation device designed to target a region deep in the brain linked to chronic pain.


Developments in Fibromyalgia Treatments 2012

This group of articles, published in 2012 at various sources, evaluates status of commonly prescribed recommendations and treatments for Fibromyalgia.

"Fibro Doctors Chose Pfizer Over You "(Fibromyalgia Network, posted May 30, 2012) An editorial by Kristin Thorson, founder and editor of the Fibromyalgia Network, on the FibroCollaborative Roadmap for Change program. Disclaimer: This editorial is being provided as a source of information. The opinions expressed are those of the author and do not necessarily state or reflect the views of Massachusetts CFIDS/ME & FM Association.

"Fibro Out-of-Control?" (One of the free, sample articles available at Fibromyalgia Network) Dr. Charles Lapp and Dr. Carol Beals explain why FM symptoms get worse and offer ways to tackle.

"Increase in Diagnosis Rates and Penetration into New Markets Drives the Global Fibromyalgia Therapeutics Market, According to New Report by Global Industry Analysts, Inc." (PR Web) An article that takes a look at unmet medical needs for Fibromyalgia from a business standpoint.

"Low-Dose Naltrexone for Autoimmune Diseases and Fibromyalgia? The Unfinished Story" (ProHealth, Dec. 21, 2011)

Milnacipran Beneficial for Fibromyalgia in Patients With Inadequate Response to Duloxetine (Monthly Prescribing Reference (MPR)   Review of two FM-specific medications (i.e., milnacipran (brand name, Savella) and duloxetine (brand name, Cymbalta) that includes study observations/ recommendations made by Dr. Lucinda Bateman at The Fatigue Consultation Clinic in Salt Lake City, UT.

"Omega-3 Trial Suggests 'a Nutritional Supplement Might Actually Make a Difference in Aging'" (ProHealth) An interesting article examining some of the benefits of supplemental omega-3 fatty acids as shown in a trial, "Omega-3 fatty acids, oxidative stress, and leukocyte telomere length: A randomized controlled trial," by Kiecolt-Glaser JK, et al. Ohio State University College of Medicine and College of Public Health; University of California, San Francisco, CA, published in Brain, Behavior, and Immunity, Sept. 23, 2012.

XMRV/pMLV multi-center study disproves hypothesis 2012

The recent multi-center study published on September 18, 2012 in mBio® (the online open-access journal of the American Society for Microbiology) concludes that no evidence of XMRV (xenotropic murine leukemia virus-related virus) and pMLV (polytropic murine leukemia virus) was found in patients with Chronic Fatigue Syndrome, disproving previous findings and hypothesis.

W. Ian Lipkin of Columbia University, a co-author on the study, reported "The bottom line is we found no evidence of infection with XMRV and pMLV. These results refute any correlation between these agents and disease." (Source: Neuroscience News, September 18, 2012).

Follow the instructions below to obtain access (free) to the full-text study.  

A Multicenter Blinded Analysis Indicates No Association between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and either Xenotropic Murine Leukemia Virus-Related Virus or Polytropic Murine Leukemia Virus (American Society for Microbiology, doi:10.1128/mBio.00266-12) Link provides access to multi-center study on XMRV and ME/CFS co-authored by Harvey J. Alter, Judy A. Mikovits, William M. Switzer, Francis W. Ruscetti, Shyh-Ching Lo, Nancy Klimas, Anthony L. Komaroff, Jose G. Montoya, Lucinda Bateman, Susan Levine, Daniel Peterson, Bruce Levin, Maureen R. Hanson, Afia Genfi, Meera Bhat, HaoQiang Zheng, Richard Wang, Bingjie Li, Guo-Chiuan Hung, Li Ling Lee, Stephen Sameroff, Walid Heneine, John Coffin, Mady Hornig and W. Ian Lipkin.

Once at the mBio® site, click on the right side bar for full text display or PDF of this study. This is an open-access (OA) article released on 09/18/2012 (under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported License) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited.


Notice about names

The Massachusetts ME/CFS & FM Association would like to clarify the use of the various acronyms for Chronic Fatigue Syndrome (CFS), Chronic Fatigue & Immune Dysfunction Syndrome (CFIDS) and  Myalgic Encephalomyelitis (ME) on this site. When we generate our own articles on the illness, we will refer to it as ME/CFS, the term now generally used in the United States. When we are reporting on someone else’s report, we will use the term they use. The National Institutes of Health (NIH) and other federal agencies, including the CDC, are currently using ME/CFS. 

Massachusetts ME/CFS & FM Association changed its name in July, 2018, to reflect this consensus.